QBTS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds D-Wave Quantum Investors of Securities Class Action Lawsuit Deadline on December 15, 2026

Faruqi & Faruqi is investigating potential securities claims against D-Wave Quantum and says a federal securities class action has been filed against the company. Investors who purchased or acquired D-Wave securities from February 26 through August 25, 2026, may contact the firm; the deadline to seek lead-plaintiff status is December 15, 2026.

Analysis

This is a procedural litigation-overhang signal, not evidence in itself that the claims have merit or that any alleged disclosure issue is financially material. The key market mechanism is a possible increase in uncertainty around disclosure credibility: for a long-duration, expectation-sensitive quantum-computing equity, that can weigh on the multiple before any damages or operating impact is established. The effect should remain limited unless the complaint identifies a specific alleged misstatement, a measurable corrective disclosure, or facts that prompt a company response, restatement, or regulatory inquiry.

Near term, headline-driven volatility and reduced risk appetite are more plausible than a change in operating fundamentals. Over the next 1–3 months, monitor the complaint, lead-plaintiff process, QBTS’s response, and any disclosure or guidance revisions; do not infer broad sector read-through to quantum peers without shared facts. Over 6–18 months, the meaningful downside would be litigation exposing a broader control or disclosure problem that impairs financing credibility or delays commercial adoption. Conversely, dismissal or lack of material new disclosures would reduce the overhang. The article supplies no allegations, stock reaction, or financial exposure, so conviction and valuation conclusions are not supportable.

Key Decisions for Investors

• No standalone short recommendation from this notice. Treat the lead-plaintiff deadline as a calendar catalyst, not a merits verdict; avoid adding exposure solely on the basis of the law-firm solicitation.
• For existing QBTS positions, review event-risk limits and consider keeping size modest into filings or company commentary if the position thesis depends on trusted disclosure and long-dated execution.
• Before trading the litigation angle, verify the complaint’s specific allegations, the purported corrective disclosure and dates, any company rebuttal, and whether insurance or potential liabilities are disclosed. These are presently missing.
• Escalate to a bearish thesis only if filings or company disclosures establish material misrepresentation, trigger a restatement or regulatory action, or coincide with deteriorating operating guidance. A dismissal or no material disclosure change would weaken the overhang thesis.